Showing 581-590 of 9295 results for "".
Ask An Expert: Establish Your Expertise
https://practicaldermatology.com/youngmd-connect/resident-resource-center/ask-an-expert-establish-your-expertise/21174/Credit Card on File: Benefit or Liability?
https://practicaldermatology.com/topics/practice-management/credit-card-on-file-benefit-or-liability/20422/Think twice before asking patients for a credit card number to keep on file."Ask Me Anything" Mentorship Session With Dr. Tina Bhutani
https://practicaldermatology.com/programs/practical-dermatology/ask-me-anything-mentorship-session-with-dr-tina-bhutani/39251/Tina Bhutani, MD, MAS, FAAD, describes her career journey and answers various questions from YoungMD Connect members. YoungMD Connect is an editorially independent platform made possible by industry sponsorships. We would like to thank our silver platform sponsor, Incyte, and bronze sponsor, AlmiralThe Importance of the Atopic Dermatitis Pipeline
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37148/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, a board-certified dermatologist in San Diego, California, and Director of Clinical Dermatology at Therapeutics Clinical Research, provides an overview of important research underway involving new therapeutics for the treatment of atopContributing Factors to Persistent or Adult-Onset Atopic Dermatitis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/contributing-factors-to-persistent-or-adult-onset-atopic-dermatitis/48773/Zoe Diana Draelos, MD, discusses potential reasons for the increasing prevalence of atopic dermatitis in adults, especially in certain parts of the world.NIH Analysis Examines Association Between AD and Comorbidities
https://practicaldermatology.com/programs/practical-dermatology-atopic-dermatitis/nih-analysis-examines-association-between-ad-and-comorbidities/27113/In this week's DermwireTV, new NIH data looks at the association between AD and several health conditions; a study evaluates the effect of lebrikizumab monotherapy in patients with moderate-to-severe AD over 16 weeks; and Andrew Mastro provides tips on how to optimize the first 5 minutes with a patiNoah Worcester 2024: Dr. Gottlieb on Psoriatic Arthritis
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-gottlieb-psoriatic-arthritis/24594/Alice Gottlieb, MD, PhD, summarizes her lecture on the critical role of the dermatologist in preventing disability due to psoriatic arthritis at the 2024 Noah Worcester Dermatological Society meeting.An Inside Look at How Incyte is Addressing Unmet Needs of Patients with Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/an-inside-look-at-how-incyte-is-addressing-unmet-needs-of-patients-with-atopic-dermatitis/20156/Ahmad Naim, Vice President of US Medical Affairs at Incyte, discusses the challenges around atopic dermatitis (AD) management and how Incyte is utilizing its expertise in immunology to address unmet needs for patients.What to do if your practice’s social accounts are inactive
https://practicaldermatology.com/topics/practice-management/what-to-do-if-your-practices-social-accounts-are-inactive/20127/Social media is the can’t miss marketing platform of 2022. However, it has been around long enough that many businesses have already tried it and given up years ago. If you are among the many dermatology practices with an old, outdated, nearly inactive Facebook or other social accounts, check out thDermWireTV: Dupixent for Kids; Epsolay Launch; Scleroderma Awareness; Chicago Derms Celebrate Diversity
https://practicaldermatology.com/topics/practice-management/dermwiretv-dupixent-for-kids-epsolay-launch-scleroderma-awareness-chicago-derms-celebrate-diversity/20100/Epsolay (benzoyl peroxide 5%) Cream from Galderma is now available for the topical treatment of rosacea. It was developed by Sol-Gel. Dupixent from Sanofi and Regeneron is now the only biologic medicine FDA approved for use from infancy through adulthood for the management of atopic dermatitis. June